Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2010, Vol. 30 Issue (02): 44-48    
研究报告     
人MCM7 N-端融合蛋白的原核表达、纯化及其与AR蛋白相互作用的研究
师以康1**,余金喜2,顾黎1
1.山东大学国家糖工程技术研究中心 济南 250012
2.山东省枣庄矿业集团中心医院 枣庄 277011
Expression, Purification of N-terminus Fusion Human MCM7 and a Study on Its Interaction with AR
1.National Glycoengineering Research Center, Shandong University, Jinan 250012, China
2.Central Hospital of Zaozhuang Coal Mining Group Co. Ltd, Zaozhuang 277011, China
 全文: PDF(476 KB)   HTML
摘要:

目的:制备人MCM7 N-端的GST融合蛋白(GST-MCM7N),研究其是否和雄激素受体(AR)蛋白存在直接的相互作用。方法:利用RT-PCR获得长度为744 bp的人mcm7 基因N-端cDNA碱基片段,把该片段构建到原核表达载体pGEX-5x-3中,转化大肠杆菌BL-21菌株。经IPTG诱导菌株基因表达产生了GST-MCM7N融合蛋白;使用Glutathione Sepharose 4B球珠分离纯化。利用GST pull-down 技术把纯化的融合蛋白分别和前列腺癌细胞LNCaP细胞裂解液及基因工程获得的AR蛋白孵育,检测MCM7蛋白的 N-端是否和AR蛋白直接相互作用。结果:酶切鉴定及基因测序表明,mcm7 基因cDNA的 N-端片段被构建到表达载体pGEX-5x-3中;SDS-PAGE及Western blotting结果分别显示,本研究获得了GST和GST-MCM7N融合蛋白;GST pull-down 结果证实GST-MCM7N和AR蛋白存在相互作用。结论:MCM7蛋白的N-端和AR蛋白至少在体外可以发生直接的相互作用。

关键词: MCM7AR蛋白相互作用GST融合蛋白    
Abstract:

744 bp of N- terminal of mcm7 gene was amplified by PCR and was cloned into prokaryotic expressing vector pGEX-5x-3 to construct pGEX-5x-3/MCM7N. A batch of E.coli BL-21 were transformed with pGEX-5x-3 and pGEX-5x-3/MCM7N, respectively. GST protein and GST-MCM7N fusion protein were obtained from the recombinant E. coli BL-21 after IPTG induction and were purified with Glutathione Sepharose 4B. The fusion proteins with 54 kDa molecular weight were specifically recognized by both anti-GST antibody and anti-MCM7 antibody in Western blotting analyses. GST pull-down analysis showed that GST-MCM7N fusion proteins interacted directly with androgen receptor (AR) protein after GST-MCM7N incubated with prostate cancer LNCaP cell lysate and His-AR fusion protein, respectively. The result demonstrated that the N- terminal of MCM7 protein can interact directly with AR in vitro.

Key words: MCM7    AR    Protein interaction    GST fusion protein
收稿日期: 2009-06-12 出版日期: 2010-02-26
基金资助:

山东省优秀中青年科学家科研奖励基金资助项目(2008BS02003)

通讯作者: 师以康     E-mail: shiyikang@yahoo.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
师以康
余金喜
顾黎

引用本文:

师以康 余金喜 顾黎. 人MCM7 N-端融合蛋白的原核表达、纯化及其与AR蛋白相互作用的研究[J]. 中国生物工程杂志, 2010, 30(02): 44-48.

SHI Si-Kang, TU Jin-Chi, GU Li. Expression, Purification of N-terminus Fusion Human MCM7 and a Study on Its Interaction with AR. China Biotechnology, 2010, 30(02): 44-48.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/        https://manu60.magtech.com.cn/biotech/CN/Y2010/V30/I02/44

[1] Costa A, Onesti S. The MCM complex: (just) a replicative helicase? Biochem Soc Trans, 2008, 36(Pt 1):136140. 
[2] Labib K, Tercero J A,Difley J F.Uninterrupted MCM27 function required for DNA replication fork progression. Science, 2000, 288(5471):16431647. 
[3] Ren B, Yu G, Tseng G C, et al. MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene, 2006, 25:10901098. 
[4] Fujioka S, Shomori K, Nishihara K, et al. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication. Lung Cancer, 2009, 65(2):223229. 
[5] Nishihara K, Shomori K, Fujioka S, et al. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Int J Oncol, 2008, 33(2):245251. 
[6] Nieto M, Finn S, Loda M, et al. Prostate cancer: Refocusing on androgen receptor signaling. Int J Biochem Cell Biol, 2007, 39(9):15621568. 
[7] Golias C H, Iliadis I, Peschos D, et al. Amplification and coregulators of androgen receptor gene in prostate cancer. Ex POncol, 2009, 31(1):38. 
[8] Honeycutt K A, Chen Z, Koster M I, et al. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogen, 2006, 25(29):40274032. 
[9] Koch H B, Zhang R, Verdoodt B, et al. Largescale identification of cMYCassociated proteins using a combined TAP/MudPIT approach. Cell Cycle, 2007, 6(2):205217. 
[10] Buchsbaum S, Morris C, Bochard V, et al. Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle. Oncogene, 2007, 26(35):51325144. 
[11] Tsao C C, Geisen C, Abraham R T. Interaction between human MCM7 and Rad17 proteins is required for replication checkpoint signaling. EMBO J, 2004, 23(23):46604669. 
[12] Tsvetkov L, Stern D F. Interaction of chromatinassociated Plk1 and Mcm7. J Biol Chem, 2005, 280(12):1194311947. 
[13] Ryu M J, Kim B J, Lee J W, et al. Direct interaction between cohesin complex and DNA replication machinery. Biochem Biophys Res Commun, 2006, 341 (3): 770775. 
[14] 韩昱晨,官忠燕,段红梅,等.酵母双杂交技术筛选肺癌组织中MCM7蛋白结 合蛋白, 中国肺癌杂志, 2008,11(4):509512. Han Y C, Guan Z Y, Duan H M, et al. Chineses Journal of Lung Cancer, 2008,11(4): 509512.
[15] Kraus S, Gioeli D, Vomastek T, et al. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor, Cancer Res, 2006, 66(22):1104711054.

[1] 栗波,王泽建,梁剑光,刘爱军,李海东. 等离子体作用结合氧限制模型选育利福霉素SV高产菌株 *[J]. 中国生物工程杂志, 2021, 41(2/3): 38-44.
[2] 彭海丽,侯占铭. MDT1基因参与禾谷镰刀菌分生孢子发生和营养生长 *[J]. 中国生物工程杂志, 2020, 40(8): 10-18.
[3] 郭晶,侯占铭. Folpcs1基因对尖孢镰刀菌亚麻专化型的无性繁殖和营养生长的调控 *[J]. 中国生物工程杂志, 2020, 40(3): 48-64.
[4] 谢华玲,吕璐成,杨艳萍. 全球冠状病毒疫苗专利分析[J]. 中国生物工程杂志, 2020, 40(1-2): 57-64.
[5] 潘彤彤,陈永平. 重型/危重型新型冠状病毒肺炎关键治疗技术研究进展[J]. 中国生物工程杂志, 2020, 40(1-2): 78-83.
[6] 肖雪筠,唐奇,新华·那比. 靶向肿瘤微环境的CAR-T治疗研究*[J]. 中国生物工程杂志, 2020, 40(12): 67-74.
[7] 廖小艳,陈丽丽. COVID-19疫苗研究现状*[J]. 中国生物工程杂志, 2020, 40(12): 8-17.
[8] 陈曼,王爱先,傅旻婧,吴雪英,甄军毅,宫美维,郭亚,王卉. CAR细胞疗法在T细胞-急性淋巴细胞白血病应用的新进展[J]. 中国生物工程杂志, 2019, 39(9): 103-107.
[9] 田园,李艳玲. 基于重组毕赤酵母的fusaruside生物合成 *[J]. 中国生物工程杂志, 2019, 39(7): 8-14.
[10] 张正坦,朱婧,谢志平. 酿酒酵母全基因组SNARE蛋白的亚细胞定位研究 *[J]. 中国生物工程杂志, 2019, 39(10): 44-57.
[11] 赵悦,吴昊,乔建军. 细菌细胞壁生长调控机制研究进展 *[J]. 中国生物工程杂志, 2018, 38(8): 92-99.
[12] 舒群峰,徐美娟,李静,张显,杨套伟,许正宏,饶志明. 钝齿棒杆菌中异源表达N-乙酰鸟氨酸脱乙酰基酶合成L-鸟氨酸的研究 *[J]. 中国生物工程杂志, 2018, 38(7): 29-39.
[13] 毕晴,孙琳. CAR-T技术中外专利申请分析与比较[J]. 中国生物工程杂志, 2018, 38(4): 107-114.
[14] 袁小川, 连芳, 赵荫农, 陈闯, 黄山, 李科志, 曾爱屏, 何剑波, 邬国斌. 基于电泳温度提升建立大鼠肝快速透明化模型[J]. 中国生物工程杂志, 2017, 37(9): 65-70.
[15] 余琳,王建华,葛良鹏. 靶向Glypican-3的肝癌免疫治疗研究进展*[J]. 中国生物工程杂志, 2017, 37(12): 90-95.